Recall of products by Lupin Sun Pharma and Glenmark Pharmaceuticals from US Market Kumar Jeetendra | January 22, 2019 India’s major drug making organization Lupin has recalled their various drugs from the US market because of multiple reasons. Sun Pharma & Glenmark Pharmaceuticals have also recalled their products from the US market. According to the current Enforcement Report which was issued by the USFDA, Lupin is recalling 55,000 vials & 1,60,241 boxed of anti-bacterial …
To treat influenza FDA approved a new drug Kumar Jeetendra | November 2, 2018 The U.S FDA administration has recently approved a new drug for the treatment of influenza (Flu). This drug Xofluza (baloxavirmarboxil) will be used for the treatment of the acute uncomplicated influenza (flu) in patients who are currently 12 years and older who have been symptomatic for no more than 48 hours. Flu is usually caused …
Father of Molecular Microbial Pathogenesis Dies at 84 Kumar Jeetendra | May 22, 2018 Stanley Falkow who was known as the Father of Molecular MicrobialPathogenesisdied on May 5, 2018. His age was 84 when he died at his home in Portola Valley, California.His wife, Lucy Tompkins, who is also a professor at Stanford said that cause was complications of myelodysplastic syndrome, a rare disorder in which the bone marrow …
Are we treating Urinary Tract Infections right Kumar Jeetendra | February 23, 2018 Infections are as old as mankind. The discovery of antibiotics gave us the power to control infections. Bacteriae were smarter to develop ways to escape action of antibiotics and that’s what we now call as Antibiotic resistance. The antibiotic resistance spread far and wide and currently is one of the main concerns plaguing the medical …
Scientists identified protein help to survive in flu Kumar Jeetendra | February 8, 2018 Researcher from Penn State identified a protein compound while working with lung function of mice with influenza, compound named GM-CSF – a protein that modifies the immune response to the flu, may also help reduce lung inflammation and improve survival during influenza. Researcher E. Scott Halstead said that the results suggested that the GM-CSF could …
Syngene Launches new mini Multi Application Imaging System Kumar Jeetendra | October 28, 2017 Syngene Bangalore based Biotech Company is a world-leading manufacturer of image analysis solutions, today launched the G:BOX mini, a compact, upgradable, multi-application system for all types of gel and Western blot imaging.rn Featuring a motorized stage, high performance camera and the option to add HI-LED lighting, this system is an ideal solution for laboratories that …
Laboratory on the Fingertips A Revolution in Healthcare Kumar Jeetendra | June 1, 2017 The surrounding and environment around us keep on changing and at times you may get exposed to a number of health issues. Obesity is one such problem which has now crawled into the lives of teenagers and young adults. Similarly, there are many other health related issues which have started to affect us. Whatever you …
Winter conceived babies increase diabetes risk in mothers: Study warns Kumar Jeetendra | December 1, 2016 According to a new research led by the University of Adelaide, women who conceive in winters are at a higher risk of developing gestational diabetes during pregnancy, increasing a range of risk factors for both child and mother, a new study has warned. The study which investigated more than 60,000 births in South Australia over …
A Researcher Uncovered The Mystery Over The Presence Of Bacterial Colony In Infant Airways: May Help In Protection From Lung Disease Kumar Jeetendra | August 10, 2016 Researcher from University of Alabama at Birmingham presented an interesting research work which covers a mysterious thought over the presence of bacterial colony in the airways of newly born baby. Till now it was well known thought that airways are sterile until after birth. Research suggests this is true that airway of infant is colonized …
Stem Cell Therapy Potential Treatment For Cancer: Use Of New Technology To Kill Leukemia Cells Kumar Jeetendra | August 9, 2016 Researcher from UC Davis Comprehensive Cancer Center recently presented new technology hope for potential treatment of cancer in the future. Technology involve development of antisense DNA by using Monoclonal antibody for acute lymphoblastic leukemia cells, which may offer best potential treatment for the disease. The concern research recently appears in the journal Molecular Medicine. The …
New Class Of Drug Has Combo Effect Of Treating Diabetes As Well As Bone Loss: Research Study Kumar Jeetendra | August 8, 2016 Researcher from Scripps Research Institute recently discovered class of new drug order to help in increasing bone mass by expanding bone formation and bone turn over: Common process of replacement of old bone. Typically Diabetes 2 is condition closely related with bone loss and fractures and certain diabetes drug helps in increasing this risk. Th …
Stem Cell Therapy: Hope For Potential Glaucoma Treatment Kumar Jeetendra | August 5, 2016 Researcher from Veterans Affairs Research Communications shows an study over mouse resulting treatment of glaucoma by infusion of stem cells. The study may play lead role in treatment of glaucoma in future. Glaucoma is a damage of optical nerve associated with a buildup of pressure inside the eye. "We believe that replacement of damaged or …
